UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-world treatment trends and triple class exposed status in newly diagnosed multiple myeloma patients in Japan: A retrospective claims database study

PloS one, 2024-09, Vol.19 (9), p.e0310333

2024

Volltextzugriff (PDF)

Progression of disease within 24 months (POD24) in multiple myeloma implicates poor prognosis and limitations of current prediction models for POD24

Scientific reports, 2024-10, Vol.14 (1), p.22861-9, Article 22861

2024

Volltextzugriff (PDF)

Function of NLRP3 inflammasome activation in multiple myeloma

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2399367

2024

Volltextzugriff (PDF)

The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2403205

2024

Volltextzugriff (PDF)

Bispecific antibodies in the treatment of multiple myeloma

Blood cancer journal (New York), 2024-09, Vol.14 (1), p.158-17, Article 158

2024

Volltextzugriff (PDF)

Circular RNA_0003489 reflects unfavorable treatment response and shortened survival in newly diagnosed multiple myeloma patients who receive bortezomib-based induction therapy

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2399419

2024

Volltextzugriff (PDF)

In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo

Cell death & disease, 2024-10, Vol.15 (10), p.731-18, Article 731

2024

Volltextzugriff (PDF)

Targeting GPRC5D for multiple myeloma therapy

Journal of hematology and oncology, 2024-09, Vol.17 (1), p.88-19, Article 88

2024

Volltextzugriff (PDF)

Whole-genome sequencing reveals cellular origin of concomitant chronic lymphocytic leukemia and multiple myeloma: a case report

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2403203

2024

Volltextzugriff (PDF)

Current state of genetic analysis in multiple myeloma and future perspectives

Rinshō ketsueki, 2024, Vol.65 (9), p.1066

2024

Volltextzugriff (PDF)

Addition of elotuzumab to backbone treatment regimens for multiple myeloma: an updated meta-analysis of randomized clinical trials

Clinical lymphoma, myeloma and leukemia, 2024-09

2024

Volltextzugriff (PDF)

Dr. Raymond Alexanian: Pioneering Contributions to Multiple Myeloma Research, Treatment, and the Concept of Curability

Clinical lymphoma, myeloma and leukemia, 2024-09

2024

Volltextzugriff (PDF)

Improving Health Outcomes Through Treatment Sequencing Optimization in Multiple Myeloma: A Simulation Model in Transplant-Ineligible Patients

Cancer reports, 2024-10, Vol.7 (10), p.e70027

2024

Volltextzugriff (PDF)

Angiogenesis and multiple myeloma: Exploring prognostic potential of adrenomedullin

Cancer medicine (Malden, MA), 2024-09, Vol.13 (18), p.e70250-n/a

2024

Volltextzugriff (PDF)

Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets

Cell death & disease, 2024-09, Vol.15 (9), p.672-12, Article 672

2024

Volltextzugriff (PDF)

Targeting epigenetic regulation and post-translational modification with 5-Aza-2’ deoxycytidine and SUMO E1 inhibition augments T-cell receptor therapy

Journal for immunotherapy of cancer, 2024-09, Vol.12 (9), p.e008654

2024

Volltextzugriff (PDF)

Lipid levels and multiple myeloma risk: insights from Meta-analysis and mendelian randomization

Lipids in health and disease, 2024-09, Vol.23 (1), p.299-11, Article 299

2024

Volltextzugriff (PDF)

Role of CAR-T in multiple myeloma and coordination between referring and treating centers

Rinshō ketsueki, 2024, Vol.65 (9), p.1042

Yoshihara, Satoshi

2024

Volltextzugriff (PDF)

Lambda light chain - restricted non - crystalline proximal tubulopathy with cast nephropathy in multiple myeloma: a case report and literature review

BMC nephrology, 2024-09, Vol.25 (1), p.324-6, Article 324

2024

Volltextzugriff (PDF)

Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma

Communications biology, 2024-10, Vol.7 (1), p.1249-15, Article 1249

2024

Volltextzugriff (PDF)

Effective Treatment with Venetoclax and Hypomethylating Agents for the Coexistence of Multiple Myeloma and Acute Myeloid Leukemia: A Case Report and Literature Review

Annals of clinical and laboratory science, 2024-07, Vol.54 (4), p.553

2024

Volltextzugriff (PDF)

Immune microenvironment and immunotherapy resistance in multiple myeloma

Rinshō ketsueki, 2024, Vol.65 (9), p.1058

Ishibashi, Mariko

2024

Volltextzugriff (PDF)

Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores

Research and practice in thrombosis and haemostasis, 2024-09, p.102571, Article 102571

2024

Volltextzugriff (PDF)

Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients

Blood cancer journal (New York), 2024-09, Vol.14 (1), p.159-8, Article 159

2024

Volltextzugriff (PDF)

1 – 25 von 246

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

Neu hinzugefügt... seit 30 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopecia

Real-world treatment trends and triple class exposed status in newly diagnosed multiple myeloma patients in Japan: A retrospective claims database study

Progression of disease within 24 months (POD24) in multiple myeloma implicates poor prognosis and limitations of current prediction models for POD24

Function of NLRP3 inflammasome activation in multiple myeloma

The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients

Bispecific antibodies in the treatment of multiple myeloma

Circular RNA_0003489 reflects unfavorable treatment response and shortened survival in newly diagnosed multiple myeloma patients who receive bortezomib-based induction therapy

In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo

Targeting GPRC5D for multiple myeloma therapy

Whole-genome sequencing reveals cellular origin of concomitant chronic lymphocytic leukemia and multiple myeloma: a case report

Current state of genetic analysis in multiple myeloma and future perspectives

Addition of elotuzumab to backbone treatment regimens for multiple myeloma: an updated meta-analysis of randomized clinical trials

Dr. Raymond Alexanian: Pioneering Contributions to Multiple Myeloma Research, Treatment, and the Concept of Curability

Improving Health Outcomes Through Treatment Sequencing Optimization in Multiple Myeloma: A Simulation Model in Transplant-Ineligible Patients

Angiogenesis and multiple myeloma: Exploring prognostic potential of adrenomedullin

Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets

Targeting epigenetic regulation and post-translational modification with 5-Aza-2’ deoxycytidine and SUMO E1 inhibition augments T-cell receptor therapy

Lipid levels and multiple myeloma risk: insights from Meta-analysis and mendelian randomization

Role of CAR-T in multiple myeloma and coordination between referring and treating centers

Lambda light chain - restricted non - crystalline proximal tubulopathy with cast nephropathy in multiple myeloma: a case report and literature review

Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma

Effective Treatment with Venetoclax and Hypomethylating Agents for the Coexistence of Multiple Myeloma and Acute Myeloid Leukemia: A Case Report and Literature Review

Immune microenvironment and immunotherapy resistance in multiple myeloma

Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores

Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients

Aktive Filter

Suchergebnisse filtern